Advertisement for orthosearch.org.uk
Results 1 - 12 of 12
Results per page:
Bone & Joint 360
Vol. 12, Issue 1 | Pages 5 - 7
1 Feb 2023
Karthikappallil D


Bone & Joint 360
Vol. 13, Issue 2 | Pages 8 - 12
1 Apr 2024
Craxford S


Bone & Joint 360
Vol. 9, Issue 6 | Pages 5 - 11
1 Dec 2020
Sharma V Turmezei T Wain J McNamara I


Bone & Joint 360
Vol. 8, Issue 6 | Pages 3 - 8
1 Dec 2019
Pulido PG Donell S McNamara I


Bone & Joint 360
Vol. 6, Issue 3 | Pages 2 - 6
1 Jun 2017
Das A Shivji F Ollivere BJ


Bone & Joint 360
Vol. 5, Issue 4 | Pages 4 - 15
1 Aug 2016
Sehat K

Anatomical total knee arthroplasty alignment versus conventional mechanical alignment; or a combination?


Bone & Joint 360
Vol. 4, Issue 4 | Pages 8 - 11
1 Aug 2015
McBride A Nicol S Monsell F


Bone & Joint 360
Vol. 4, Issue 5 | Pages 2 - 7
1 Oct 2015
Clark GW Wood DJ

The use of robotics in arthroplasty surgery is expanding rapidly as improvements in the technology evolve. This article examines current evidence to justify the usage of robotics, as well as the future potential in this emerging field.


Bone & Joint 360
Vol. 3, Issue 1 | Pages 7 - 10
1 Feb 2014
Stahel PF

The “Universal Protocol” (UP) was launched as a regulatory compliance standard by the Joint Commission on 1st July 1 2004, with the primary intent of reducing the occurrence of wrong-site and wrong-patient surgery. As we’re heading into the tenth year of the UP implementation in the United States, it is time for critical assessment of the protocol’s impact on patient safety related to the incidence of preventable never-events. This article opens the debate on the potential shortcomings and pitfalls of the UP, and provides recommendations on how to circumvent specific inherent vulnerabilities of this widely established patient safety protocol.


Bone & Joint 360
Vol. 3, Issue 3 | Pages 2 - 8
1 Jun 2014
Phillips JRA Waterson HB Searle DJ Mandalia VI Toms AD

This is the second of a series of reviews of registries. This review looks specifically at worldwide registry data that have been collected on knee arthroplasty, what we have learned from their reports, and what the limitations are as to what we currently know.


Bone & Joint 360
Vol. 2, Issue 5 | Pages 2 - 7
1 Oct 2013
Penn-Barwell JG Rowlands TK

Blast and ballistic weapons used on the battlefield cause devastating injuries rarely seen outside armed conflict. These extremely high-energy injuries predominantly affect the limbs and are usually heavily contaminated with soil, foliage, clothing and even tissue from other casualties. Once life-threatening haemorrhage has been addressed, the military surgeon’s priority is to control infection.

Combining historical knowledge from previous conflicts with more recent experience has resulted in a systematic approach to these injuries. Urgent debridement of necrotic and severely contaminated tissue, irrigation and local and systemic antibiotics are the basis of management. These principles have resulted in successful healing of previously unsurvivable wounds. Healthy tissue must be retained for future reconstruction, vulnerable but viable tissue protected to allow survival and avascular tissue removed with all contamination.

While recent technological and scientific advances have offered some advantages, they must be judged in the context of a hard-won historical knowledge of these wounds. This approach is applicable to comparable civilian injury patterns. One of the few potential benefits of war is the associated improvement in our understanding of treating the severely injured; for this positive effect to be realised these experiences must be shared.


Bone & Joint 360
Vol. 2, Issue 6 | Pages 2 - 8
1 Dec 2013
Jones R Wood D

This article provides an overview of the role of genomics in sarcomas and describes how new methods of analysis and comparative screening have provided the potential to progress understanding and treatment of sarcoma. This article reviews genomic techniques, the evolution of the use of genomics in cancer, the current state of genomic analysis, and also provides an overview of the medical, social and economic implications of recent genomic advances.